FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to novel compounds of formula (V), compounds of formula (IX), compounds of formula (XIII) or their tautomers or pharmaceutically acceptable salts, which are capable of inducing Hsp70, as well as to pharmaceutical composition, which contains claimed compounds.
Value of substituents in formulas (V), (IX) and (XIII) are such, as claimed in invention formula.
EFFECT: obtaining pharmaceutically acceptable salts, which have possibility of inducing Hsp70.
12 cl, 12 ex, 36 dwg, 2 tbl
Title |
Year |
Author |
Number |
SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USING AS INHIBITORS OF ALIPHATIC ACIDS OXIDATION |
2002 |
- Ibrakhim Prabkha
- Shenk Kevin
- Ehlzein Ehlfatikh
- Palle Venkata
- Zablotski Dzheff
- Reder Kennet
|
RU2300533C2 |
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) |
2018 |
- Eriksson, Anna
- Grin, Nil
- Gustafson, Gari
- Khan, Binsun
- Lanchia, Ml. Devid R.
- Mitchell, Lorna
- Richard, Devid
- Shelekhin, Tatyana
- Smit, Chejz K.
- Van, Chzhungo
- Chzhen, Syaochzhan
|
RU2736217C2 |
SPIROINDOLINONE DERIVATIVES |
2007 |
- Chehn' Li
- Din Tsintszi
- Lju Tszin'Tszjun'
- Jan Son
- Chzhan Chzhumin
|
RU2435771C2 |
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS |
2009 |
- Ueta Kiitiro
- Arakava Kendzi
- Matsusita Jasuaki
|
RU2481106C2 |
ANALOGUES OF BENZOQUINONE-CONTAINING ANSAMYCINS (VERSIONS), METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION (VERSIONS) AND CANCER TREATMENT METHOD (VERSIONS) |
2004 |
- Adams Dzhulian
- Gao Jun'
- Georges Ehvangelinos Asimina T.
- Gren'E Lui
- Porter Dzhejms R.
- Pehk Rodzher Kh.
- Rajt Dzhejms L.
|
RU2484086C9 |
PREPARATION COMPRISING INHIBITOR OF HETEROTRIMERIC G PROTEINS SIGNAL TRANSDUCTION IN COMBINATION WITH OTHER CYTOSTATIC AGENT FOR THERAPEUTIC USING IN CANCER TREATMENT |
2000 |
- Prevo Greguar
- Lonsham Mari-Odil'
- Gordon Tomas
- Morgan Barri
|
RU2298417C2 |
BENZOTHIEPINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC STATE |
1997 |
- Rejts Dehvid B.
- Li Len F.
- Li Dzhinglin Dzh.
- Khuang Khorng-Chin
- Tremont Samuehl' Dzh.
- Miller Rehjmond E.
- Banerdzhi Shamal S.
|
RU2202549C2 |
METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS |
2001 |
- Lefteris Kehterina
- Behrrish Dzhoel
- Khines Dzhon
- Vrobleski Stiven T.
|
RU2316556C2 |
THERAPEUTIC COMPOSITIONS OF 4'-HALOGEN-CONTAINING NUCLEOTIDES AND NUCLEOSIDES AND USE THEREOF |
2019 |
- Pejnter, Dzhordzh R.
- Perriman, Devid
- Blumling, Gregori R.
|
RU2819040C2 |
PHARMACEUTICAL COMBINATIONS CONTAINING PYRIDO[4,3-d]PYRIMIDINE DERIVATIVES AS HSP90 INHIBITOR AND HER2 INHIBITOR |
2009 |
- Karlos Garsija-Ehcheverrija
- Mikaehl' Jensen
|
RU2532375C2 |